~ May 08 D-Ribose: Energize Your Heart, Save Your Life - References

References

1. Sinatra ST, Roberts JC. Enhancing cardiac energy with ribose. Life Extension. 2007 May;13(50):26-31.

2. Gao L, Laude K, Cai H. Mitochondrial Pathophysiology, Reactive Oxygen Species, and Cardiovascular Diseases. Vet Clin North Am Small Anim Pract. 2008 Jan;38(1):137-55.

3. Kumar D, Lou H, Singal PK. Oxidative stress and apoptosis in heart dysfunction. Herz. 2002 Nov;27(7):662-8.

4. Sorescu D, Griendling KK. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail. 2002 May;8(3):132-40.

5. Gustafsson AB, Gottlieb RA. Heart mitochondria: gates of life and death. Cardiovasc. 2008 Feb 1;77(2):334-43.

6. Zimmer HG, Ibel H. Ribose accelerates the repletion of the ATP pool during recovery from reversible ischemia of the rat myocardium. J Mol Cell Cardiol. 1984 Sep;16(9):863-6.

7. St Cyr JA, Bianco RW, Schneider JR, et al. Enhanced high energy phosphate recovery with ribose infusion after global myocardial ischemia in a canine model. J Surg Res. 1989 Feb;46(2):157-62.

8. Ward HB, Wang T, Einzig S, Bianco RW, Foker JE. Prevention of ATP catabolism during myocardial ischemia: a preliminary report. J Surg Res. 1983 Apr;34(4):292-7.

9. Wyatt DA, Ely SW, Lasley RD, et al. Purine-enriched asanguineous cardioplegia retards adenosine triphosphate degradation during ischemia and improves postischemic ventricular function. J Thorac Cardiovasc Surg. 1989 May;97(5):771-8.

10. Smolenski RT, Raisky O, Slominska EM, et al. Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply. Circulation. 2001 Sep 18;104(12 Suppl 1):I246-52.

11. Zimmer HG, Martius PA, Marschner G. Myocardial infarction in rats: effects of metabolic and pharmacologic interventions. Basic Res Cardiol. 1989 May;84(3):332-43.

12. Thirunavukkarasu M, Penumathsa S, Juhasz B, et al. Enhanced cardiovascular function and energy level by a novel chromium (III)-supplement. Biofactors. 2006;27(1-4):53-67.

13. Thirunavukkarasu M, Penumathsa SV, Juhasz B, et al. Niacin-bound chromium enhances myocardial protection from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H820-6.

14. Pauly DF, Pepine CJ. Ischemic heart disease: metabolic approaches to management. Clin Cardiol. 2004 Aug;27(8):439-41.

15. Pauly DF, Johnson C, St Cyr JA. The benefits of ribose in cardiovascular disease. Med Hypotheses. 2003 Feb;60(2):149-51.

16. Hegewald MG, Palac RT, Angello DA, Perlmutter NS, Wilson RA. Ribose infusion accelerates thallium redistribution with early imaging compared with late 24-hour imaging without ribose. J Am Coll Cardiol. 1991 Dec;18(7):1671-81.

17. Perlmutter NS, Wilson RA, Angello DA, et al. Ribose facilitates thallium-201 redistribution in patients with coronary artery disease. J Nucl Med. 1991 Feb;32(2):193-200.

18. Wallen WJ, Belanger MP, Wittnich C. Preischemic administration of ribose to delay the onset of irreversible ischemic injury and improve function: studies in normal and hypertrophied hearts. Can J Physiol Pharmacol. 2003 Jan;81(1):40-7.

19. Omran H, Illien S, MacCarter D, St CJ, Luderitz B. D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. Eur J Heart Fail. 2003 Oct;5(5):615-9.

20. Pliml W, von AT, Stablein A, et al. Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet. 1992 Aug 29;340(8818):507-10.

21. Choo J, Burke LE, Pyo HK. Improved quality of life with cardiac rehabilitation for post-myocardial infarction patients in Korea. Eur J Cardiovasc Nurs. 2007 Sep;6(3):166-71.

22. Ades PA. Individualized preventive care in cardiac rehabilitation: adapted from AACVPR Award of Excellence Lecture, Charleston, WVa, October, 2006. J Cardiopulm Rehabil Prev. 2007 May;27(3):130-4.

23. Moore SM, Dolansky MA, Ruland CM, Pashkow FJ, Blackburn GG. Predictors of women's exercise maintenance after cardiac rehabilitation. J Cardiopulm Rehabil. 2003 Jan;23(1):40-9.

24. Annesi J. Relations of self-motivation, perceived physical condition, and exercise-induced changes in revitalization and exhaustion with attendance in women initiating a moderate cardiovascular exercise regimen. Women Health. 2005;42(3):77-93.

25. Hellsten-Westing Y, Norman B, Balsom PD, Sjodin B. Decreased resting levels of adenine nucleotides in human skeletal muscle after high-intensity training. J Appl Physiol. 1993 May;74(5):2523-8.

26. Stathis CG, Febbraio MA, Carey MF, Snow RJ. Influence of sprint training on human skeletal muscle purine nucleotide metabolism. J Appl Physiol. 1994 Apr;76(4):1802-9.

27. Hellsten Y, Richter EA, Kiens B, Bangsbo J. AMP deamination and purine exchange in human skeletal muscle during and after intense exercise. J Physiol. 1999 Nov 1;520 Pt 3:909-20.

28. Tullson PC, John-Alder HB, Hood DA, Terjung RL. De novo synthesis of adenine nucleotides in different skeletal muscle fiber types. Am J Physiol. 1988 Sep;255(3 Pt 1):C271-7.

29. Zarzeczny R, Brault JJ, Abraham KA, Hancock CR, Terjung RL. Influence of ribose on adenine salvage after intense muscle contractions. J Appl Physiol. 2001 Oct;91(4):1775-81.

30. Tullson PC, Terjung RL. Adenine nucleotide synthesis in exercising and endurance-trained skeletal muscle. Am.J Physiol. 1991 Aug;261(2 Pt 1):C342-7.

31. Brault JJ, Terjung RL. Purine salvage to adenine nucleotides in different skeletal muscle fiber types. J Appl Physiol. 2001 Jul;91(1):231-8.

32. Hellsten Y, Skadhauge L, Bangsbo J. Effect of ribose supplementation on resynthesis of adenine nucleotides after intense intermittent training in humans. Am J Physiol Regul Integr Comp Physiol. 2004 Jan;286(1):R182-8.

33. Berardi JM, Ziegenfuss TN. Effects of ribose supplementation on repeated sprint performance in men. J Strength Cond Res. 2003 Feb;17(1):47-52.

34. Dunne L, Worley S, Macknin M. Ribose versus dextrose supplementation, association with rowing performance: a double-blind study. Clin J Sport Med. 2006 Jan;16(1):68-71.

35. Kerksick C, Rasmussen C, Bowden R, et al. Effects of ribose supplementation prior to and during intense exercise on anaerobic capacity and metabolic markers. Int J Sport Nutr Exerc Metab. 2005 Dec;15(6):653-64.

36. Op ‘t EB, Van LM, Brouns F, et al. No effects of oral ribose supplementation on repeated maximal exercise and de novo ATP resynthesis. J Appl Physiol. 2001 Nov;91(5):2275-81.

37. Peveler WW, Bishop PA, Whitehorn EJ. Effects of ribose as an ergogenic aid. J Strength Cond Res. 2006 Aug;20(3):519-22.

38. Segal S, Foley J, Wyngaarden JB. Hypoglycemic effect of D-ribose in man. Proc Soc Exp Biol Med. 1957 Jul;95(3):551-5.

39. Gross M, Reiter S, Zollner N. Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency. Klin Wochenschr. 1989 Dec 4;67(23):1205-13.

40. Dimroth P, von BC, Meier T. Catalytic and mechanical cycles in F-ATP synthases. Fourth in the Cycles Review Series. EMBO Rep. 2006 Mar;7(3):276-82.

41. Jain M, Cui L, Brenner DA, et al. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation. 2004 Feb 24;109(7):898-903.

42. Pacher P, Szabo C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev. 2007;25(3):235-60.

43. Zimmer HG. The oxidative pentose phosphate pathway in the heart: regulation, physiological significance, and clinical implications. Basic Res Cardiol. 1992 Jul;87(4):303-16.

44. Zimmer HG. Regulation of and intervention into the oxidative pentose phosphate pathway and adenine nucleotide metabolism in the heart. Mol Cell Biochem. 1996 Jul;160-161:101-9.

45. Clay MA, Stewart-Richardson P, Tasset DM, Williams JF. Chronic alcoholic cardiomyopathy. Protection of the isolated ischaemic working heart by ribose. Biochem Int. 1988 Nov;17(5):791-800.

46. Parang P, Singh B, Arora R. Metabolic modulators for chronic cardiac ischemia. J Cardiovasc Pharmacol Ther. 2005 Dec;10(4):217-23.

47. Pauly DF, Pepine CJ. D-Ribose as a supplement for cardiac energy metabolism. J Cardiovasc Pharmacol Ther. 2000 Oct;5(4):249-58.

48. Kendler BS. Supplemental conditionally essential nutrients in cardiovascular disease therapy. J Cardiovasc Nurs. 2006 Jan;21(1):9-16.

49. Lamberts RR, Caldenhoven E, Lansink M, et al. Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats. Am J Physiol Heart Circ Physiol. 2007;293:H1869-H1876.

50. Teitelbaum JE, Johnson C, St CJ. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med. 2006;12:857-62.


Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.